Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Lactoferrin–beta-glucan complex is a bioactive assembly consisting of the iron-binding glycoprotein lactoferrin and the glucose polymer beta-glucan. It is primarily investigated as a therapeutic delivery system or a functional food ingredient rather than a biological target itself. In this complex, lactoferrin contributes its innate antimicrobial, anti-inflammatory, and antioxidant properties, while beta-glucan serves as an immunomodulatory scaffold that can enhance the stability and cellular uptake of the protein. The complex is designed to exploit the synergistic effects of both components, particularly in modulating the immune response through interactions with receptors such as Dectin-1 and Toll-like receptors on macrophages and dendritic cells. Research suggests its potential application in treating infections, enhancing vaccine efficacy, and providing targeted nutritional support in inflammatory conditions.
The complex acts as a synergistic therapeutic agent where lactoferrin provides antimicrobial and immunomodulatory effects while beta-glucan acts as an adjuvant and targeting ligand for dectin-1 receptors on immune cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactoferrin–beta-glucan complex (LF-BG complex).